Tran Evelyn, Cabán María, Meng Alicia, Wetmore John B, Ottman Ruth, Siegel Karolynn
Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.
Columbia University Irving Medical Center, Gertrude H. Sergievsky Center, New York, New York, USA.
Int J Geriatr Psychiatry. 2025 Jul;40(7):e70128. doi: 10.1002/gps.70128.
Latinos experience significant health disparities for Alzheimer's disease (AD) with an increased likelihood in developing the disease relative to non-Latino Whites. Our study sought to examine Latinos' beliefs about controlling the symptoms and progression of AD to identify gaps in community knowledge and improve understanding of culturally based perceptions of health and illness.
We conducted in-depth, semi-structured interviews in English or Spanish with 216 Latinos aged 40-60 years (average age 53 years) living in the neighborhoods of northern Manhattan. We asked them whether they believed there were interventions that could help control AD. The data was analyzed using content analysis.
Most participants viewed medications as important in the management of AD, though they had limited specific knowledge about existing medications for AD. Some participants thought herbal and nutritional supplements could have some benefits. Many believed activities for mental stimulation could help enhance cognitive functioning. A few suggested that a healthy diet and exercise could help slow the progression of AD. Some participants believed that emotional wellness and degree of support influenced AD progression.
Limited knowledge of available medications and evidence-based non-medical approaches to control AD may adversely impact help-seeking behavior and use of effective management strategies among those with AD. Future interventions should strive to expand knowledge about ways to effectively manage and treat AD in Latino communities.
The ClinicalTrials.gov ID is NCT04471779. The date registered was July 15, 2020.
拉丁裔在阿尔茨海默病(AD)方面存在显著的健康差异,相对于非拉丁裔白人,他们患该病的可能性更高。我们的研究旨在调查拉丁裔对控制AD症状和进展的看法,以找出社区知识方面的差距,并增进对基于文化的健康和疾病观念的理解。
我们用英语或西班牙语对居住在曼哈顿北部社区的216名40至60岁(平均年龄53岁)的拉丁裔进行了深入的半结构化访谈。我们询问他们是否相信有干预措施可以帮助控制AD。使用内容分析法对数据进行了分析。
大多数参与者认为药物在AD管理中很重要,尽管他们对现有的AD药物的具体知识有限。一些参与者认为草药和营养补充剂可能有一些益处。许多人认为精神刺激活动有助于提高认知功能。少数人建议健康的饮食和锻炼可以帮助减缓AD的进展。一些参与者认为情绪健康和支持程度会影响AD的进展。
对可用药物和基于证据的非药物控制AD方法的了解有限,可能会对AD患者的求助行为和有效管理策略的使用产生不利影响。未来的干预措施应努力扩大拉丁裔社区中关于有效管理和治疗AD方法的知识。
ClinicalTrials.gov标识符为NCT04471779。注册日期为2020年7月15日。